Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06561321

Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

Led by Indiana University · Updated on 2026-03-04

6

Participants Needed

1

Research Sites

165 weeks

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

O

Organon and Co

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to assess adults with palmoplantar keratoderma (thickening skin layer on palms and soles) who are treated with the study drug, tapinarof. This is a naturally occuring compound used for the treatment of psoriasis. This study is being done to find out how well and safe this drug is for stopping or treating keratoderma. This study aims to investigate the positive impacts of daily topical Tapinarof use in the improvement of Keratoderma. Clinical efficacy and safety profile of prescribing Tapinarof for this condition will be evaluated.

CONDITIONS

Official Title

Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to provide written informed consent and follow all study requirements
  • Male or female adults aged 18 years or older
  • Confirmed clinical diagnosis of palmoplantar keratoderma
Not Eligible

You will not qualify if you...

  • Use of topical corticosteroids, keratolytic agents, topical retinoids, topical vitamin D ointment, or oral retinoids during the study without a 2-week washout period
  • Prior treatment with tapinarof
  • Known or suspected hypersensitivity to tapinarof or similar drugs
  • Participation in another clinical study for the same purpose
  • Currently pregnant or confirmed pregnancy at screening
  • Any other condition deemed unsuitable by the investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Indiana University Department of Dermatology

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

A

Austin Routh, MPH, CPH

CONTACT

F

Flossy Lincoln

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here